XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
RSU activity for the nine months ended September 30, 2025 was as follows:

RSUsWeighted-average grant date fair value per unit
RSUs unvested as of December 31, 2024
4,764,133$6.18 
Granted
3,596,390 $6.86 
Vested
(2,709,672)$6.25 
Forfeited
(528,054)$6.41 
RSUs unvested as of September 30, 2025
5,122,797$6.60 
Schedule of Stock Option Activity
A summary of stock option activity under the Company’s equity plans and related information is as follows (in thousands, except share, price and year data):
 Outstanding
stock
options
Weighted-
average
exercise
Price
Weighted-
average
remaining
contractual
life (years)
Aggregate
intrinsic
value
Balance as of December 31, 2024
6,378,753 $7.28 
Options granted— $— 
Options exercised(1,352,497)$3.46 
Options canceled(242,417)$10.95 
Balance as of September 30, 2025
4,783,839 $8.18 4.57$18,137 
Vested and exercisable as of September 30, 2025
4,757,668 $8.11 4.56$18,137 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The following table summarizes the Black-Scholes option pricing model used in estimating the fair value of the stock purchase rights under the ESPP during the nine months ended September 30, 2025 and 2024. There were no ESPP offerings or modification events requiring an estimation of fair value during the three months ended September 30, 2025 and 2024.
Nine Months Ended September 30,
20252024
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
Expected volatility
61% - 70%
48% - 56%
Risk-free interest rate
3.97% - 4.32%
4.82% - 5.43%
Expected dividend yield%%
Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation expense included in the condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):
Three Months Ended September 30,
Nine Months Ended September 30,
2025202420252024
Cost of revenue
$318 $478 $1,170 $1,218 
Research and development
2,564 3,097 9,303 7,455 
Sales and marketing
1,230 2,908 4,908 6,492 
General and administrative
1,333 1,955 4,727 4,330 
Total stock-based compensation expense
$5,445 $8,438 $20,108 $19,495